CN Patent

CN114315897B — 一种磷酸特地唑胺新晶体及其制备方法

Assigned to Jilin Huikang Pharmaceutical Co ltd · Expires 2024-05-17 · 2y expired

What this patent protects

本发明提供一种新型磷酸特地唑胺晶体及其制备方法，其特征在于，其晶体为类球状。所述类球状晶体，其晶体外观性状好，粒径分布合理，流动性好，利于制剂工艺的操作，为制备稳定可控的制剂产品提供了保障，并且，制备的新型晶体，相比于现有的棒状晶体，澄清度更好，具有更好的稳定性。

USPTO Abstract

本发明提供一种新型磷酸特地唑胺晶体及其制备方法，其特征在于，其晶体为类球状。所述类球状晶体，其晶体外观性状好，粒径分布合理，流动性好，利于制剂工艺的操作，为制备稳定可控的制剂产品提供了保障，并且，制备的新型晶体，相比于现有的棒状晶体，澄清度更好，具有更好的稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN114315897B
Jurisdiction
CN
Classification
—
Expires
2024-05-17
Drug substance claim
No
Drug product claim
No
Assignee
Jilin Huikang Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.